Repligen (RGEN) Reports In-Line Q4 EPS, Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $143.94 +4.75%
EPS Growth %: +21.6%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +21.6%
Financial Fact:
Product revenue: 24.68M
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q4 EPS of $0.21, in-line with the analyst estimate of $0.21. Revenue for the quarter came in at $51.9 million versus the consensus estimate of $50.4 million.
GUIDANCE:
Repligen sees FY2019 EPS of $0.81-$0.86, versus the consensus of $0.85. Repligen sees FY2019 revenue of $218-225 million, versus the consensus of $217.25 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Angi Inc. names new chief accounting officer after resignation
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
